Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-16, Stock:ABBV, The news for the past five days is as follows:
2020-06-09: NEWS1: Roche, Johnson & Johnson Top R&D Spenders in 2019.NEWS2: Tuesday Morning Market Highlights.NEWS3: AbbVie Is Concocting a Formula for a Breakout.
2020-06-10: NEWS1: This Biotech Just Hit Pay Dirt On A Potential $3 Billion Deal With AbbVie.NEWS2: AbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the Original.NEWS3: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS4: Wednesday Morning Market Highlights.NEWS5: AbbVie Signs $3.9 Billion Oncology Deal with Genmab.NEWS6: AbbVie Can Withstand Humira’s Decline With New Drugs.NEWS7: AbbVie and Genmab Ink $4 Billion Cancer-Treatment Pact.NEWS8: ESG Investing Trend to Stay Strong Post Pandemic: 5 Top Picks.NEWS9: Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with Rheumatoid Arthritis.NEWS10: Genmab Shares Rise 5% In Pre-Market On Oncology Partnership With AbbVie.NEWS11: Genmab's stock surges after drug development deal with AbbView valued at up to nearly $4 billion.NEWS12: AbbVie and Genmab Announce Broad Oncology Collaboration.
2020-06-11: NEWS1: AbbVie Inks Deal With Genmab, Announces ADC Candidate Data.NEWS2: Top Ranked Value Stocks to Buy for June 11th.NEWS3: AbbVie (ABBV) Hits 52-Week High, Can the Run Continue?.NEWS4: 3 Wins for AbbVie in 3 Days Provide 3 More Good Reasons to Buy the Pharma Stock.
2020-06-12: NEWS1: AbbVie Recommends Shareholders Reject TRC Capital's &quot;Mini-Tender&quot; Offer.NEWS2: AbbVie Presents New Late-Breaking Data Showing SKYRIZI® (risankizumab-rzaa) Achieves Superior Rates of Complete Skin Clearance Versus COSENTYX® (secukinumab) at 52 Weeks.NEWS3: The Zacks Analyst Blog Highlights: AbbVie, Eagle Bancorp Montana, H&R Block, Mackinac Financial and Virtu Financial.NEWS4: 5 Defensive Stocks to Buy as Coronavirus Cases Rise Again.NEWS5: Pharma Stock Roundup: Coronavirus Updates From ABBV, LLY, JNJ, FDA Approvals.NEWS6: COVID-19 cases surge, officials issue warnings.NEWS7: Go Defensive to Beat Market Turbulence With These 4 Stocks.NEWS8: AbbVie Jumped Into The Coronavirus Drug Hunt — Is AbbVie Stock A Buy?.
2020-06-15: NEWS1: Merck's Gardasil Gets FDA Approval for Head and Neck Cancers.NEWS2: Roche (RHHBY) Presents Positive Data on Venclexta at EHA 2020.NEWS3: FDA Approves JUVÉDERM® VOLUMA™ XC for Enhancement of the Chin Region.NEWS4: AbbVie to Showcase 27 Studies at the Virtual 2020 Annual Scientific Meeting of the American Headache Society.

Answer: Rise